News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioFocus DPI Launches Academic Engagement Initiative



5/1/2013 11:01:39 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Saffron Walden, UK (1 May 2013) – BioFocus announced today that it has launched its Academic Engagement initiative (AEi). Based on years of experience working with academic and non-profit institutions, the primary aim of the initiative is to identify the best new therapeutic strategy ideas from academic groups, and to provide an effective and user-friendly mechanism to progress these ideas towards high quality chemical matter. As part of the interaction model, BioFocus will contribute to grant writing and will provide ideas on funding mechanisms, but will not seek to retain any IP related to the projects; this will remain with the idea-originating institution.

“BioFocus has been assisting researchers to translate their discoveries into small molecule space for many years and will continue to enable these exciting early-stage projects,” said Professor Julie Frearson, BioFocus’ Senior Director Scientific Alliances and Translational Programs. “BioFocus is also well positioned to take key projects to preclinical proof of concept and beyond towards candidate nomination.”

For further information on BioFocus’ AEi please contact BioFocus: www.biofocus.com/contact.

Contacts

BioFocus:

Professor Julie Frearson

Tel: +44 1799 533 500

Email: Julie.frearson@glpg.com

Media enquiries:

Katie Odgaard

Zyme Communications

Tel: +44 7787 502 947

Email: katie.odgaard@zymecommunications.com

About BioFocus

BioFocus provides integrated drug discovery that delivers pre-clinical drug candidates in all therapeutic areas with strong capabilities in neurodegenerative diseases, inflammatory diseases and rare and neglected diseases. BioFocus has advanced and comprehensive drug discovery capabilities that are applied to client projects to deliver targets, hits, leads and pre-clinical candidates. The company employs over 150 exceptionally qualified and industry experienced scientists at its research centers in the UK and the Netherlands. Since its foundation in 1997, BioFocus has produced high quality data for its clients, assured by ISO9001 qualification, validated by regular independent inspection of all BioFocus research centers. For more information, visit us at Twitter, LinkedIn and at www.biofocus.com.

BioFocus® is a trademark of Galapagos NV and/or its affiliates © Copyright 2013 Galapagos NV.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES